In these experiments, we detected a significant 40% decrease in the mammary tumor volume upon ebselen oxide administration that was perfectly correlated with tumor weight and similar to what we described with zuclopenthixol, another moesin‐mimicking compound we identified [14]. The gene discussed is MSN; the disease is neoplasm.